Get email updates from SABCSMeetingNews.org
Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.
Aditya Bardia, MD, MPH, will moderate a Friday afternoon session on the latest advances and strategies to target the estrogen receptor gene mutation in breast cancer, including novel drug therapies in development.
Prevention, early detection, and interception were the focus of the second Speccial Session on Tuesday at the 2023 SABCS®. Presenter Joanne Kotsopoulos, PhD, discussed use of hormones in patients with BRCA 1 and 2 mutations.
Hans-Christian Kolberg, MD, PhD, discusses a Friday morning poster presentation analyzing the neoadjuvant neoMono trial.
Sacha Howell, PhD, FRCP, and Angel Guerrero-Zotano, MD, PhD, discuss their Friday morning poster presentations.
Malcolm Bevel, PhD, MSPH; Richard J. Bleicher, MD, FACS; and Marcela Mazo-Canola, MD, discuss their Friday morning poster presentations.
Findings from the HER2CLIMB-02 trial and late-breaking final overall survival results from MONARCH 3 were presented on Wednesday during the first General Session of the 2023 SABCS®.
Jack Cuzick, PhD, a pioneer in breast cancer prevention research, received the William L. McGuire Memorial Lecture Award on Wednesday.
SABCS® Program Director Kate Lathrop, MD, shares a few highlights from Thursday’s schedule to help you plan your day, including Poster Spotlight Sessions and notable General Session abstracts.
Don’t miss Thursday’s General Session abstract presentations and Poster Spotlight Session presentations, featuring research that has the potential to shape the future of breast cancer care.
Frederick Howard, MD, discusses a Thursday afternoon presentation on whether inflammatory breast cancer is a genomically different type of breast cancer.